Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 14, 2014; 20(18): 5375-5388
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5375
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5375
Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation
Jae Seon Eo, Department of Nuclear Medicine, Korea University Anam Hospital, Seoul 136-701, South Korea
Jin Chul Paeng, Dong Soo Lee, Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul 110-744, South Korea
Author contributions: Eo JS and Paeng JC drafted the article; Lee DS substantially contributed to conception.
Correspondence to: Jin Chul Paeng, MD, PhD, Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, South Korea. paengjc@snu.ac.kr
Telephone: +82-2-20723341 Fax: +82-2-7669083
Received: September 27, 2013
Revised: October 23, 2013
Accepted: November 3, 2013
Published online: May 14, 2014
Revised: October 23, 2013
Accepted: November 3, 2013
Published online: May 14, 2014
Core Tip
Core tip: Nuclear imaging methods including single photon emission computed tomography (SPECT) and positron emission tomography (PET) are increasingly being used in the management of liver malignancy. In this review, the efficacy and clinical role of nuclear imaging methods are discussed with regard to fluorodeoxyglucose PET and other PET or SPECT imaging methods. In particular, the application of nuclear imaging for theragnosis and surgical intervention including transplantation is discussed in detail. This review may be helpful for understanding current trends of nuclear imaging for liver malignancy.